Literature DB >> 11298186

Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

A O'Regan1, J S Berman.   

Abstract

Osteopontin (Opn) is a secreted adhesive, glycosylated phosphoprotein that contains the arginine-glycine-aspartic acid (RGD) cell-binding sequence that is found in many extracellular matrix (ECM) proteins (for a review of Opn see References Denhardt & Guo 1993; Patarca et al. 1993; Rittling & Denhardt 1999). Since its initial description in 1979 as a secreted protein associated with malignant transformation, Opn has been independently discovered by investigators from diverse scientific disciplines, and has been associated with a remarkable range of pathologic responses. Opn is an important bone matrix protein, where it is thought to mediate adhesion of osteoclasts to resorbing bone. However, studies from the past decade have identified an alternative role for Opn as a key cytokine regulating tissue repair and inflammation. Recent work by our laboratory and that of others has underlined the importance of Opn as a pivotal cytokine in the cellular immune response. Despite this Opn is not well known to the immunologist. In this review we will focus on studies that pertain to the role of Opn in cell-mediated and granulomatous inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11298186      PMCID: PMC2517746          DOI: 10.1046/j.1365-2613.2000.00163.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  112 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.

Authors:  Y U Katagiri; J Sleeman; H Fujii; P Herrlich; H Hotta; K Tanaka; S Chikuma; H Yagita; K Okumura; M Murakami; I Saiki; A F Chambers; T Uede
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Osteopontin. Between a rock and a hard plaque.

Authors:  L L Demer; Y Tintut
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

5.  Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency.

Authors:  M Nemir; D Bhattacharyya; X Li; K Singh; A B Mukherjee; B B Mukherjee
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

6.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

Authors:  K N Cowan; P L Jones; M Rabinovitch
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

7.  Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis?

Authors:  T Mustafa; S Phyu; R Nilsen; G Bjune; R Jonsson
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

8.  A regulated interaction between alpha5beta1 integrin and osteopontin.

Authors:  S T Barry; S B Ludbrook; E Murrison; C M Horgan
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

9.  Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties.

Authors:  M T Kaartinen; A Pirhonen; A Linnala-Kankkunen; P H Mäenpää
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

10.  Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro.

Authors:  A W O'Regan; G L Chupp; J A Lowry; M Goetschkes; N Mulligan; J S Berman
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  86 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.

Authors:  Tara Sabo-Attwood; Maria E Ramos-Nino; Maria Eugenia-Ariza; Maximilian B Macpherson; Kelly J Butnor; Pamela C Vacek; Sean P McGee; Jessica C Clark; Chad Steele; Brooke T Mossman
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.

Authors:  Cedric Hunter; Jennifer Bond; Paul C Kuo; Maria Angelica Selim; Howard Levinson
Journal:  J Surg Res       Date:  2011-08-27       Impact factor: 2.192

4.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis.

Authors:  R Marciano; F Giacopelli; M T Divizia; M Gattorno; E Felici; A Pistorio; A Martini; R Ravazzolo; P Picco
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

5.  Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas.

Authors:  R Sedivy; K Peters; G Klöppel
Journal:  Virchows Arch       Date:  2004-11-26       Impact factor: 4.064

6.  Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-10       Impact factor: 7.328

7.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.

Authors:  SongTao Qi; GuangLong Huang; Jun Pan; Jia Li; Xi'An Zhang; LuXiong Fang; BaoGuo Liu; Wei Meng; YongMing Zhang; XiaoJun Liu
Journal:  J Neurooncol       Date:  2009-11-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.